Clinical utility of intralesional methotrexate to distinguish crateriform keratinocytic tumors before surgery

JDDG: Journal der Deutschen Dermatologischen GesellschaftVolume 20, Issue 1 p. 102-105 Clinical LetterOpen Access Clinical utility of intralesional methotrexate to distinguish crateriform keratinocytic tumors before surgery Rafael Salido-Vallejo, Corresponding Author Rafael Salido-Vallejo rsalidov@unav.es Department of Dermatology, University Clinic of Navarra, School of Medicine, University of Navarra, Pamplona, Spain Department of Dermatology, Reina Sofía University Hospital, Córdoba, Spain Correspondence to Rafael Salido-Vallejo, MD, PhD Department of Dermatology University Clinic of Navarra, School of Medicine University of Navarra Avda. Pio XII, 36 31008 Pamplona, Spain E-mail: rsalidov@unav.esSearch for more papers by this authorJuan Luis Sanz-Cabanillas, Juan Luis Sanz-Cabanillas Department of Dermatology, Reina Sofía University Hospital, Córdoba, SpainSearch for more papers by this authorJorge María Núñez-Córdoba, Jorge María Núñez-Córdoba Research Support Service, Central Clinical Trials Unit, University Clinic of Navarra, Pamplona, SpainSearch for more papers by this authorAlberto González-Menchen, Alberto González-Menchen Department of Pathology, Reina Sofía University Hospital, Córdoba, SpainSearch for more papers by this authorAntonio Vélez, Antonio Vélez Department of Dermatology, Reina Sofía University Hospital, Córdoba, SpainSearch for more papers by this authorPedro Redondo, Pedro Redondo Department of Dermatology, University Clinic of Navarra, School of Medicine, University of Navarra, Pamplona, SpainSearch for more papers by this author Rafael Salido-Vallejo, Corresponding Author Rafael Salido-Vallejo rsalidov@unav.es Department of Dermatology, University Clinic of Navarra, School of Medicine, University of Navarra, Pamplona, Spain Department of Dermatology, Reina Sofía University Hospital, Córdoba, Spain Correspondence to Rafael Salido-Vallejo, MD, PhD Department of Dermatology University Clinic of Navarra, School of Medicine University of Navarra Avda. Pio XII, 36 31008 Pamplona, Spain E-mail: rsalidov@unav.esSearch for more papers by this authorJuan Luis Sanz-Cabanillas, Juan Luis Sanz-Cabanillas Department of Dermatology, Reina Sofía University Hospital, Córdoba, SpainSearch for more papers by this authorJorge María Núñez-Córdoba, Jorge María Núñez-Córdoba Research Support Service, Central Clinical Trials Unit, University Clinic of Navarra, Pamplona, SpainSearch for more papers by this authorAlberto González-Menchen, Alberto González-Menchen Department of Pathology, Reina Sofía University Hospital, Córdoba, SpainSearch for more papers by this authorAntonio Vélez, Antonio Vélez Department of Dermatology, Reina Sofía University Hospital, Córdoba, SpainSearch for more papers by this authorPedro Redondo, Pedro Redondo Department of Dermatology, University Clinic of Navarra, School of Medicine, University of Navarra, Pamplona, SpainSearch for more papers by this author First published: 21 December 2021 https://doi.org/10.1111/ddg.14637AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Volume20, Issue1January 2022Pages 102-105 RelatedInformation